Across TCGA pan-cancer cohorts, SSNA1 mass-spec protein is linked to patient survival in 4 of 34 cancer types, making it a survival-associated SSNA1 data layer compared with 25 for mass-spec protein and 3 for mutation status.
The strongest signal is observed in colon adenocarcinoma (COAD), where higher SSNA1 mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated SSNA1 expression acts as an unfavorable survival marker, although some lineages such as UCEC and LSCC show a favorable association.
COAD, CCRCC, and UCEC are the cancer types where SSNA1 mass-spec protein most reproducibly stratifies survival.